Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 2/20 | 0.55 |
| ▸ | NTRK2 | Q16620 | 3/20 | 0.52 |
| ▸ | RET | P07949 | 12/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | AXL | P30530 | 2/20 | 0.42 |
| ▸ | MERTK | Q12866 | 2/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27315227 | 0.87 | NTRK1 (0.55) | NTRK1NTRK2RETKDRAXL | |
| SCHEMBL27315615 | 0.86 | NTRK1 (0.58) | NTRK1NTRK2RET | |
| SCHEMBL27315170 | 0.83 | NTRK1 (0.57) | NTRK1NTRK2RETMEN1NPC1 | |
| SCHEMBL27315239 | 0.81 | RET (0.51) | RETAXLMERTKAURKAAURKB | |
| SCHEMBL27315205 | 0.78 | NTRK1 (0.54) | NTRK1NTRK2RETKDRAXL | |
| SCHEMBL27315108 | 0.74 | NTRK1 (0.57) | NTRK1NTRK2RETKDR | |
| SCHEMBL27315059 | 0.73 | NTRK1 (0.56) | NTRK1NTRK2RETKDRAURKA | |
| SCHEMBL1924757 | 0.71 | NTRK1 (1.00) | NTRK1NTRK2RETMEN1KMT2A | |
| SCHEMBL1925208 | 0.70 | NTRK1 (0.89) | NTRK1NTRK2RETNPC1RAB9A | |
| SCHEMBL1925269 | 0.69 | NTRK1 (0.88) | NTRK1NTRK2RETKDRAXL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611900-A1 | RET-LDD PROTEIN INHIBITORS | Bristol-Myers Squibb Company (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097980-A1 | RET-LDD PROTEIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-05-10 | — | — | WO | disclosed |